Potassium Citrate.

Magnesium is needed for sodium-potassium ATPase and it restrains renal potassium loss. Low magnesium makes any potassium intake harder to retain.

Both salts deliver citrate, which is metabolised to bicarbonate and raises urinary citrate and pH. Pairing them stacks the alkali load as well as the two minerals.

Citrate binds calcium in urine and keeps it in solution, while the potassium salt lowers urinary calcium excretion. The two citrate salts act on the same urinary chemistry from different sides.

The alkali load from citrate reduces urinary calcium loss, so more of a calcium intake stays in the body. This is the long-standing reason potassium citrate appears in bone formulas.

A high sodium load raises urinary calcium and potassium loss, which is the effect potassium citrate is added to offset. The sodium to potassium ratio is what the body reads.

Vitamin D raises intestinal calcium absorption while the citrate alkali load lowers urinary calcium loss. The two act on opposite ends of the same balance.

Large ascorbic acid doses acidify urine and add to the oxalate pool, working against the alkalinising direction of citrate. Where the alkali effect is the point, a high vitamin C dose partly cancels it.

Glycyrrhizin drives renal potassium excretion through mineralocorticoid receptor activity. It pushes against whatever potassium the citrate salt supplies.

Sodium and potassium are handled together in the distal nephron, where sodium reabsorption drives potassium secretion. Total intake of one changes how the kidney handles the other, which is why intake studies almost always report the pair. This is settled renal physiology rather than a supplement combination finding.

Citrate is metabolised in the liver to bicarbonate, so potassium citrate and sodium bicarbonate deliver alkali by different routes and add together. The difference between them is the accompanying cation, potassium in one case and sodium in the other. Anyone tracking sodium intake should count both. The additivity is chemistry, not a trial result.

An alkali load reduces urinary calcium excretion, so citrate salts and a calcium supplement interact through the same renal handling step. Citrate also binds calcium in urine and keeps it in solution. Studies in this area report urinary and blood turnover markers rather than structural outcomes, so read the connection as biochemical.

Vitamin K2 is the cofactor that carboxylates osteocalcin so it can bind calcium in the bone matrix. Potassium citrate acts on a different lever, the acid load the kidney has to buffer. The two are combined in bone-support formulas on that mechanistic separation, not on a study that tested them together.

A magnesium taurate and potassium citrate combination was studied in adults with elevated blood pressure, so the pairing exists as a tested formulation rather than a proposal. Taurine contributes as the magnesium counter-ion in that product, which makes attributing any signal to taurine alone impossible. What the report speaks to is the combination.

Low magnesium increases potassium loss through the renal outer medullary potassium channel, so potassium is hard to retain while magnesium is depleted. Correcting magnesium is a standard part of correcting potassium. Glycinate is one magnesium form among several and the point holds for any of them. This is textbook renal physiology.

Urinary pH governs which calcium salts stay dissolved: raising pH keeps calcium oxalate in solution better but favours calcium phosphate crystal formation. Citrate raises urinary pH and citrate excretion at the same time. Anyone combining it with a phosphate load is changing two variables that pull in different directions. That trade-off is standard urinary chemistry.

Potassium citrate is a common potassium carrier in electrolyte blends because it is more palatable than the chloride and contributes alkali rather than acid. Its contribution is potassium plus a metabolisable anion. Total potassium across all sources is the number that matters, not the salt names on the panel.

Alanine glyoxylate aminotransferase is a pyridoxal-phosphate-dependent enzyme, and it diverts glyoxylate away from becoming oxalate. Potassium citrate acts downstream by keeping urinary calcium oxalate in solution. The two therefore address different points in the same chemistry. No trial pairing them was located.

Both salts deliver potassium, but the citrate anion is metabolised to bicarbonate and the chloride anion is not, so only one adds alkali. Chloride is the appropriate anion when chloride itself is being replaced, such as after heavy loss from vomiting. Counting total potassium across both is the practical point. This is a difference in the anion, not a ranking of the salts.

Effervescent and drink-mix formats built on citrate salts commonly carry botanical flavour components such as ginger. The pairing is about palatability and gastric tolerance of a salty alkali load. No physiological interaction between the two was identified.